As CYP2C9 enzyme metabolises pro-carcinogenic xenobiotic compounds such as- polycyclic aromatic hydrocarbons and heterocyclic aromatic amines- in the intestinal epithelium, it leads to an increased risk of cancer [35]. Here, CYP2C9 is linked to cancer.